The clinical nuance: Routine baseline lipase/amylase is not universally mandated by guidelines, but is clinically reasonable particularly if a patient has a history of pancreatitis, cholelithiasis (gallstones), hypertriglyceridemia, or heavy alcohol use Symptom-triggered testing is the standard response: any severe, persistent upper abdominal pain radiating to the back during GLP-1 therapy should prompt immediate evaluation, not a scheduled lab appointment Ask your doctor: "Given my history, do you recommend a baseline lipase, and what symptoms should prompt me to seek immediate evaluation?" Question 6: What Will My Cholesterol and Lipid Panel Look Like on GLP-1s
Sleep quality changes during treatment While the long-term trajectory is typically positive for sleep, the short-term experience can be more variable
5 Furthermore, the significant and often rapid weight loss achieved with these medications has raised concerns about the risk of sarcopenia because up to 40% of total weight loss is lean mass
doi: 10.1073/pnas.1514282112 54 RichterTACaicedoARoperSD
Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimers disease indicate possible resistance to IGF-1 and insulin signalling
The active ingredients are the same as in Wegovy, Ozempic, Mounjaro, and Zepbound